Boston Scientific Corporation

World Rank (Jul-30-2023)
200
Market Cap (Jul-30-2023)
74.315 Billion USD
World Rank (Dec-25-2022)
211
Market Cap (Dec-25-2022)
65.972 Billion USD
World Rank (Jan-07-2022)
301
Market Cap (Jan-07-2022)
60.006 Billion USD
World Rank (Jan-01-2021)
315
Market Cap (Jan-01-2021)
50.913 Billion USD
Company Rank in Country in 2023
Company Rank in USA in July-2023 is 109
Annual Revenue in USD
12,682 Million USD
Annual Net Income in USD
642 Million USD
Total Assets in USD
32,469 Million USD
Total Liabilities in USD
14,896 Million USD
Annual Results for Year ending in
Dec-2022 month
Headquarters State / City
Massachusetts
Headquarters Country
USA
Company Business
Healthcare
Medical Equipment
HealthCare Products
Stock Category
S&P 500
Stock Exchange
NYSE
Frankfurt
Company Rank in Country in 2022
Company Rank in USA in 2022 is 151
Rank in Country (Jan-2021)
Company Rank in USA in 2021 is 152
Rank in Country (Jan-2020)
Rank in USA in 2020 is 108
Number of Employees
51,000
Employee Count as on Date
As on 2022
CEO:
Michael F. Mahoney
Founders
Peter Nicholas
John Abele
Yahoo
Yahoo @ NYSE
Wikipedia
Wikipedia
Facebook
Facebook
Company Website:
BOSTON SCIENTIFIC CORPORATION
About Company Business:

BOSTON SCIENTIFIC CORPORATION is Medical Device manufacturing company with headquarters in USA. Boston Scientific is dedicated to transforming lives through innovative medical solutions that improve the health of patients around the world.

BOSTON SCIENTIFIC CORPORATION  have 25,000 employees in 40 countries across six continents are committed to doing business sustainably and responsibly in the communities where we live and work.

As on 2022, BOSTON SCIENTIFIC CORPORATION has 51,000 employees.

BOSTON SCIENTIFIC CORPORATION annual revenue generated for period ending Dec-2022 was 12,682 million USD.

BOSTON SCIENTIFIC CORPORATION annual net income generated for period ending Dec-2022 was 642 million USD.

Explore BOSTON SCIENTIFIC CORPORATION Businesses

  • Endoscopy
  • Cardiology
  • Nuromodulation
  • Peripheral Interventions
  • Rhythem Management
  • Urology and Pelvic Health

BOSTON SCIENTIFIC CORPORATION annual revenue generated for period ending Dec-2021 was 11,888 million USD.

BOSTON SCIENTIFIC CORPORATION annual net income generated for period ending Dec-2021 was 985 million USD.

Total Assets as on Dec-2021 was 32,229 Million USD.

Total Liabilities as on Dec-2021 was 15,607 Million USD.

Total Equity as on Dec-2021 was 16,622 Million USD.

 

Founded Year
1979
Annual Results Summary:

BOSTON SCIENTIFIC CORPORATION - Annual Results - Revenue and Net Income - in Million USD:

Year - Ending Revenue Operating Income Net Income
Dec-2022 12,682 2,033 642
Dec-2021 11,888 1,824 985
Dec-2020 9,913 684 -173
Dec-2019 10,735 1,740 4,700
Dec-2018 9,823 1,659 1,671
Dec-2017 9,048 1,531 104
Dec-2016 8,386   347
Balance Sheet Summary

BOSTON SCIENTIFIC CORPORATION - Balance Sheet Summary - in Million USD:

Year Ending:

 Total Assets Total Liabilities Total Equity
Dec-2022 32,469 14,896 17,573
Dec-2021 32,229 15,607 16,622
Dec-2020 30,777 15,450 15,326
Dec-2019 30,565 16,688 13,877
Dec-2018 20,999 12,273 8,726
Dec-2017 19,042 12,030 7,012
Quarterly Results Summary:

BOSTON SCIENTIFIC CORPORATION - Quarterly Results - Revenue and Net Income - in Million USD:

Quarterly Ending:

 Total Revenue Operating Income Net Income
Sep-2023 3,527 609 505
Jun-2023 3,599 606 261
Mar-2023 3,389 583 300
Dec-2022 3,242 526 126
Sep-2022 3,170 507 174
Jun-2022 3,244 518 246
Mar-2022 3,026 482 97
Dec-2021 3,127 479 80
Sep-2021 2,932 387 419
Jun-2021 3,077 262 186
Mar-2021 2,752 370 341
Dec-2020 2,709 50 210
Institutional Investors

Top 30 Institutional Holder Names in BOSTON SCIENTIFIC CORPORATION as on SEP-30-2023

RANK INSTITUTION NAME DATE SHARES HELD CHANGE (SHARES) CHANGE (%) VALUE (IN 1,000S)
1 BLACKROCK INC. 09/30/2023 12,93,07,129 -81,86,920 -5.95% $6,963,189
2 FMR LLC 09/30/2023 12,59,20,357 80,45,263 6.83% $6,780,811
3 VANGUARD GROUP INC 09/30/2023 12,37,68,348 15,25,432 1.25% $6,664,926
4 MASSACHUSETTS FINANCIAL SERVICES CO /MA/ 09/30/2023 6,25,33,382 -66,03,703 -9.55% $3,367,423
5 STATE STREET CORP 09/30/2023 6,19,45,856 -12,46,041 -1.97% $3,335,784
6 WELLINGTON MANAGEMENT GROUP LLP 09/30/2023 4,20,76,529 23,36,348 5.88% $2,265,821
7 PRIMECAP MANAGEMENT CO/CA/ 09/30/2023 3,73,55,169 -73,810 -0.20% $2,011,576
8 GEODE CAPITAL MANAGEMENT, LLC 09/30/2023 2,69,96,317 9,48,203 3.64% $1,453,752
9 BANK OF AMERICA CORP /DE/ 09/30/2023 2,52,91,179 -12,95,000 -4.87% $1,361,930
10 JPMORGAN CHASE & CO 09/30/2023 2,41,03,972 9,40,531 4.06% $1,297,999
11 BOLLARD GROUP LLC 09/30/2023 2,33,44,726 -3,30,355 -1.40% $1,257,113
12 DZ BANK AG DEUTSCHE ZENTRAL GENOSSENSCHAFTS BANK, FRANKFURT 09/30/2023 2,22,98,154 8,06,030 3.75% $1,200,756
13 MORGAN STANLEY 09/30/2023 2,12,00,339 4,81,891 2.33% $1,141,638
14 CITADEL ADVISORS LLC 09/30/2023 2,11,56,222 56,99,874 36.88% $1,139,263
15 JANUS HENDERSON GROUP PLC 09/30/2023 2,05,57,658 6,88,373 3.47% $1,107,030
16 ARTISAN PARTNERS LIMITED PARTNERSHIP 09/30/2023 1,78,09,043 -12,20,453 -6.41% $959,017
17 BANK OF NEW YORK MELLON CORP 09/30/2023 1,72,07,345 51,293 0.30% $926,616
18 GOLDMAN SACHS GROUP INC 09/30/2023 1,66,18,338 -21,52,877 -11.47% $894,898
19 INVESCO LTD. 09/30/2023 1,48,62,018 2,11,732 1.45% $800,320
20 AMUNDI 09/30/2023 1,48,03,910 -18,85,154 -11.30% $797,191
21 NORTHERN TRUST CORP 09/30/2023 1,38,90,530 5,31,914 3.98% $748,005
22 NORGES BANK 12/31/2022 1,36,70,207 3,44,285 2.58% $736,141
23 LEGAL & GENERAL GROUP PLC 09/30/2023 1,12,53,368 -2,51,576 -2.19% $605,994
24 MILLENNIUM MANAGEMENT LLC 09/30/2023 1,11,36,194 9,16,118 8.96% $599,684
25 VONTOBEL ASSET MANAGEMENT INC 09/30/2023 99,59,429 -9,685 -0.10% $536,315
26 NUVEEN ASSET MANAGEMENT, LLC 09/30/2023 95,62,454 2,08,515 2.23% $514,938
27 LAZARD ASSET MANAGEMENT LLC 09/30/2023 89,07,137 -2,85,441 -3.11% $479,649
28 VOYA INVESTMENT MANAGEMENT LLC 09/30/2023 84,19,859 -12,13,719 -12.60% $453,409
29 UBS ASSET MANAGEMENT AMERICAS INC 09/30/2023 76,78,013 4,41,622 6.10% $413,461
30 CHARLES SCHWAB INVESTMENT MANAGEMENT INC 09/30/2023 76,42,834 2,01,008 2.70% $411,567

Share it on Social Media